Labels

Immunoassay Market Growth Due to Increasing Incidence of Chronic and Infectious Diseases, Global Industry Analysis to 2019-2025


Meticulous Research®– leading global market research the company published a research report titled “Immunoassay Market by Product (Kits & Reagents, Analyzers, Software), Platform (Chemiluminescence, Radioimmunoassays) Application (Infectious Diseases, Cardiology), End-User (Hospitals, Academic Laboratories), and Geography – Global Forecast to 2025”.
Immunoassay Market by Meticulous Research®

According to this latest publication from MeticulousResearch®, the global immunoassay market is expected to grow at a cagr of 5.9% from 2019 to reach $19.76 billion by 2025. The high growth of the immunoassay market is mainly attributed to the increasing incidence of chronic and infectious diseases, the growing use of immunoassay in oncology, the rise in drug and alcohol testing, and technological advancements in immunoassay. In addition, emerging markets and increasing epidemic potentials offer significant growth opportunities for the players operating in this market. However, limitations of immunoassay and the development of alternative technologies are the key factors expected to hinder the adoption of immunoassay products.

The global immunoassay market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2025-by product (immunoassay kits & reagents, immunoassay analyzers, immunoassay software & services), platforms (chemiluminescence immunoassays, fluorescence immunoassays, colorimetric immunoassays, radioimmunoassays, other platforms) application (infectious diseases, cardiology, endocrinology, oncology, bone & mineral disorders, autoimmune disorders, allergy, other applications), end-user (hospitals & clinics, clinical laboratories/reference labs, blood banks, pharmaceutical and biotechnology companies, research & academic laboratories, other end users). The study also evaluates industry competitors and analyzes the market at the regional and country levels.
On the basis of product, the immunoassay kits, and reagents the segment accounted for the largest share of this market in 2018. The large share of this segment is mainly attributed to the increasing number of immunoassay tests being performed across the globe leading to the recurrent purchase of kits and reagents. Among kits and reagents segment, ELISpot kits and reagents segment is projected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the rising global incidence of chronic diseases, increasing vaccines development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot assay kits and analyzers.
On the basis of detection technology or platform incorporated, the immunoassay market comprises Chemiluminescence Immunoassays (CLIAs), Colorimetric Immunoassays (CIs), Fluorescence Immunoassays (FIAs), Radioimmunoassays (RIAs), and other platforms, including turbidimetric immunoassays and counting immunoassays. The CLIAs segment accounted for the largest share of the global immunoassays market in 2018. The large share of this segment can primarily be attributed to wide adoption of CLIAs in clinical diagnostics, research applications, and in the pharmaceutical analysis due to low cost per test and high sensitivity.
On the basis of application, infectious diseases accounted for the largest share of the global immunoassay market in 2018. The rising incidence of infectious diseases and the growing adoption of immunoassay diagnostics in infectious diseases are the key factors responsible for the large share of this segment in the market. The oncology segment is expected to grow at the highest CAGR in the forecast period. Rising prevalence of cancer, increasing focus towards tumor market development, technological advancements, and growing awareness about cancer is expected to drive the growth of this market.
The hospital's segment accounted for the largest share in 2018 and is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to a large volume of tests performed in hospitals and hospital-associated laboratories. Ease of access and need for faster turnaround time are some of the key factors that lead to a large volume of tests performed in hospitals.
This research report analyzes major geographies and provides a comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America, and Middle East & Africa. North America commanded the largest share of the global immunoassays market in 2018, followed by Europe and the Asia Pacific. However, the Asia Pacific region is expected to grow at the higher CAGR during the forecast period. The immunoassays market in the Asia Pacific, especially in China, India, and Japan is expected to witness high growth during the forecast period. Growth in this market is expected to be driven by a large pool of patient population, increasing prevalence of infectious diseases and cancer, increasing government spending on healthcare, and increasing disposable income of the population that improved the access to diagnosis and treatment. In addition, favorable government policies and healthcare structural reform are further expected to drive the market growth. Furthermore, the lack of stringent regulations and liberalization in Asian countries is also a key factor in making the Asia Pacific a lucrative market.
Key Players:- 
The major players operating in the global immunoassays market are F. Hoffman La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux (France), Ortho Clinical Diagnostics (U.S.), DiaSorin SPA (Italy), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Merck (Germany), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer (U.S.), Quidel Corporation (U.S.), Bio-Techne Corporation (U.S.), and Mindray (China) among others.
Key questions answered in the report-
  • Which are the high growth market segments in terms of product, platforms, application, end-user, and region/countries?
  • What was the historical market for immunoassay across the globe?
  • What are the market forecasts and estimates for the period 2019-2025?
  • What are the major drivers, restraints, opportunities, and challenges in the global immunoassay market?
  • Who are the major players in the global immunoassay market?
  • How is the competitive landscape and who are the market leaders in the global immunoassay market?
  • What are the recent developments in the global immunoassay market?
  • What are the different strategies adopted by the major players in the global immunoassay market?
  • What are the geographical trends and high growth regions/ countries?

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

Contact Us:

Meticulous Research®

Email- sales@meticulousresearch.com

Contact Sales- +91-744-778-0008
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Labels:

Comments

Post a Comment